Standpoint Research initiated coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $110.00.

For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.

Shares of Gilead Sciences closed at $82.71 yesterday.